Renaissance Technologies - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$55,853
-1.3%
5,799,898
+9.0%
0.10%
+15.9%
Q2 2023$56,599
+16.0%
5,319,453
+14.7%
0.08%
+26.2%
Q1 2023$48,789
-10.0%
4,637,753
+6.0%
0.06%
-12.2%
Q4 2022$54,196
-99.9%
4,374,153
-18.6%
0.07%
-6.3%
Q3 2022$55,666,000
-10.8%
5,373,153
-0.8%
0.08%
+6.8%
Q2 2022$62,439,000
+58.9%
5,415,353
+73.4%
0.07%
+60.9%
Q1 2022$39,288,000
+25.8%
3,123,053
+16.6%
0.05%
+17.9%
Q4 2021$31,240,000
+8.3%
2,679,253
+21.3%
0.04%
+5.4%
Q3 2021$28,857,000
-34.8%
2,209,553
-35.7%
0.04%
-32.7%
Q2 2021$44,248,000
+26.0%
3,438,053
+9.5%
0.06%
+25.0%
Q1 2021$35,114,000
+53.7%
3,140,753
+56.6%
0.04%
+76.0%
Q4 2020$22,846,000
+176.8%
2,005,753
+118.6%
0.02%
+212.5%
Q3 2020$8,255,000
-39.1%
917,753
-30.1%
0.01%
-33.3%
Q2 2020$13,559,000
-10.3%
1,313,853
-12.3%
0.01%
-20.0%
Q1 2020$15,119,000
+50.7%
1,498,453
+98.8%
0.02%
+87.5%
Q4 2019$10,032,000
+1257.5%
753,690
+775.8%
0.01%
+700.0%
Q3 2019$739,000
-84.7%
86,053
-75.9%
0.00%
-75.0%
Q1 2019$4,836,000
-59.4%
357,453
-43.3%
0.00%
-73.3%
Q2 2017$11,899,000
+274.1%
630,253
+238.0%
0.02%
+275.0%
Q1 2017$3,181,000
+13.2%
186,453
-23.1%
0.00%
-33.3%
Q4 2015$2,811,000
+762.3%
242,553
+676.1%
0.01%
+500.0%
Q3 2015$326,000
-61.0%
31,253
-54.9%
0.00%
-50.0%
Q2 2015$836,00069,3030.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders